Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Follow-Up of Children Born to Mothers in Folic Acid Clinical Trial (FACT 4 Child): A Prospective Cohort Study Based on a Double-Blinded Randomised Controlled Trial

Lookup NU author(s): Professor Steve RobsonORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2025 John Wiley & Sons Ltd.Objective: To assess the impact of high-dose folic acid supplementation (4.0–5.1 mg), started between 8+0 and 16+6 weeks of gestation and continued until delivery, on social impairments associated with Autism Spectrum Disorders, deficiencies in executive function, and emotional and behavioural problems in children. Design: FACT 4 Child is a follow-up of mothers and their children born during the Folic Acid Clinical Trial (FACT), an international multi-centre double-blinded randomised trial to assess the effect of high-dose folic acid supplementation on preventing preeclampsia in women with increased risk. Setting: Multi-centre international follow-up study. Population: Mothers and their children enrolled in FACT, among them 664 completed the follow-up. Methods: Mothers reported on social and executive function and emotional and behavioural problems in their children aged 4–9 years using standardised, validated questionnaires. Main Outcome: The proportion of children with at least one score > 1.5 SD above expected mean. Results: Among 319 children in the intervention group, 43 (13.5%) had a score in the elevated range, compared with 51/345 (14.8%) in the placebo group (RR = 0.91; 95% CI: 0.63 to 1.33; p = 0.63). Conclusion: In children born to women at risk for preeclampsia, rates of neurodevelopmental outcomes were not different between high-dose folic acid and control groups in this study. Our finding suggests that a high dose of folic acid supplementation may not be needed in pregnant women with increased risk. A larger-scale study is needed to determine neurodevelopmental outcomes associated with different dosages and timing of folic acid supplementation during pregnancy.


Publication metadata

Author(s): Ghiasi M, Zwaigenbaum L, Moddemann D, White RR, Dingwall-Harvey ALJ, Grattan KP, Murray M, Rybak N, Walker H, Lacaze-Masmonteil T, Asztalos E, Gaudet LM, Robson S, Hague W, Simms-Stewart D, Smith G, Bujold E, Corsi DJ, Goldfield G, El-Chaar D, Wen SW, Walker MC

Publication type: Article

Publication status: Published

Journal: BJOG: An International Journal of Obstetrics and Gynaecology

Year: 2025

Pages: epub ahead of print

Online publication date: 27/08/2025

Acceptance date: 11/08/2025

ISSN (print): 1470-0328

ISSN (electronic): 1471-0528

Publisher: John Wiley and Sons Inc

URL: https://doi.org/10.1111/1471-0528.18341

DOI: 10.1111/1471-0528.18341


Altmetrics

Altmetrics provided by Altmetric


Share